JP2013507369A - Ｇタンパク質共役受容体８８の調節因子 - Google Patents
Ｇタンパク質共役受容体８８の調節因子 Download PDFInfo
- Publication number
- JP2013507369A JP2013507369A JP2012533264A JP2012533264A JP2013507369A JP 2013507369 A JP2013507369 A JP 2013507369A JP 2012533264 A JP2012533264 A JP 2012533264A JP 2012533264 A JP2012533264 A JP 2012533264A JP 2013507369 A JP2013507369 A JP 2013507369A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- mmol
- phenyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 CC(*)CC1=CC(C)(*)C=C(C(F)(F)F)C=C1 Chemical compound CC(*)CC1=CC(C)(*)C=C(C(F)(F)F)C=C1 0.000 description 1
- WTNZAPZOSSPUHI-ACRUOGEOSA-N CCC(CC)COc1ccc([C@H](CO)NC([C@@H](C2)[C@H]2c2ccc[s]2)=O)c(C)c1 Chemical compound CCC(CC)COc1ccc([C@H](CO)NC([C@@H](C2)[C@H]2c2ccc[s]2)=O)c(C)c1 WTNZAPZOSSPUHI-ACRUOGEOSA-N 0.000 description 1
- FDGXWFLFJLMESD-FBOXXWIASA-N CCCC(C)COc1ccc([C@H](CO)NC([C@@H](C2)[C@H]2c2ccc[s]2)=O)cc1 Chemical compound CCCC(C)COc1ccc([C@H](CO)NC([C@@H](C2)[C@H]2c2ccc[s]2)=O)cc1 FDGXWFLFJLMESD-FBOXXWIASA-N 0.000 description 1
- XXQRMVONZZWLKF-DSITVLBTSA-N CC[C@@H](c(cc1)ccc1-c(cc1)ccc1OC)NC([C@@H](C1)[C@H]1c1ccccc1)=O Chemical compound CC[C@@H](c(cc1)ccc1-c(cc1)ccc1OC)NC([C@@H](C1)[C@H]1c1ccccc1)=O XXQRMVONZZWLKF-DSITVLBTSA-N 0.000 description 1
- BODVPNMHLGISLM-DSYPUSFNSA-N CC[C@H](C)COc1ccc([C@H](CN)NC([C@@H](C2)[C@H]2c2ccc[s]2)=O)c(C)c1 Chemical compound CC[C@H](C)COc1ccc([C@H](CN)NC([C@@H](C2)[C@H]2c2ccc[s]2)=O)c(C)c1 BODVPNMHLGISLM-DSYPUSFNSA-N 0.000 description 1
- OHWJVFXCFOFCAJ-ZFCZOSEKSA-N CC[C@H](C)COc1ccc([C@H](CO)NC([C@@H](C2)[C@H]2C2=CC=CSC2)=O)cc1 Chemical compound CC[C@H](C)COc1ccc([C@H](CO)NC([C@@H](C2)[C@H]2C2=CC=CSC2)=O)cc1 OHWJVFXCFOFCAJ-ZFCZOSEKSA-N 0.000 description 1
- DCGJSXHMNZQIQN-FKBYEOEOSA-N CCc(cc1)ccc1-c1cc(OC)c([C@H](CO)NC([C@@H](C2)[C@H]2c2ccc[s]2)=O)cc1 Chemical compound CCc(cc1)ccc1-c1cc(OC)c([C@H](CO)NC([C@@H](C2)[C@H]2c2ccc[s]2)=O)cc1 DCGJSXHMNZQIQN-FKBYEOEOSA-N 0.000 description 1
- BAWUIVSQZHKYDH-FKBYEOEOSA-N CCc(cc1)ccc1-c1ccc([C@H](CO)NC([C@@H](C2)[C@H]2c2ccc[s]2)=O)cc1 Chemical compound CCc(cc1)ccc1-c1ccc([C@H](CO)NC([C@@H](C2)[C@H]2c2ccc[s]2)=O)cc1 BAWUIVSQZHKYDH-FKBYEOEOSA-N 0.000 description 1
- FTJGKCRCBGQPIG-NJYVYQBISA-N Cc(cc1)ccc1-c1ccc([C@H](CO)NC([C@H](C2)[C@@H]2c2ccc[s]2)=O)cc1 Chemical compound Cc(cc1)ccc1-c1ccc([C@H](CO)NC([C@H](C2)[C@@H]2c2ccc[s]2)=O)cc1 FTJGKCRCBGQPIG-NJYVYQBISA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24946509P | 2009-10-07 | 2009-10-07 | |
| US61/249,465 | 2009-10-07 | ||
| PCT/US2010/051572 WO2011044195A1 (en) | 2009-10-07 | 2010-10-06 | Modulators of g protein-coupled receptor 88 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013507369A true JP2013507369A (ja) | 2013-03-04 |
| JP2013507369A5 JP2013507369A5 (enExample) | 2013-11-21 |
Family
ID=43480829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012533264A Withdrawn JP2013507369A (ja) | 2009-10-07 | 2010-10-06 | Ｇタンパク質共役受容体８８の調節因子 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8497271B2 (enExample) |
| EP (1) | EP2486030B1 (enExample) |
| JP (1) | JP2013507369A (enExample) |
| CN (1) | CN102686575A (enExample) |
| ES (1) | ES2428492T3 (enExample) |
| IN (1) | IN2012DN02876A (enExample) |
| WO (1) | WO2011044195A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014520785A (ja) * | 2011-07-08 | 2014-08-25 | ハー・ルンドベック・アクチエゼルスカベット | ニコチン性アセチルコリン受容体の陽性アロステリックモジュレーター |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8304577B2 (en) | 2009-10-09 | 2012-11-06 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
| US8426414B2 (en) | 2009-10-09 | 2013-04-23 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
| HRP20180913T1 (hr) | 2011-07-08 | 2018-07-27 | H. Lundbeck A/S | Pozitivni alosterni modulatori receptora nikotinskog acetilkolina |
| US8703953B2 (en) | 2012-03-09 | 2014-04-22 | Bristol-Myers Squibb Company | Aryl ether-base kinase inhibitors |
| WO2014006120A1 (en) * | 2012-07-06 | 2014-01-09 | H. Lundbeck A/S | New positive allosteric modulators of nicotinic acetylcholine receptor |
| JP2016504306A (ja) * | 2012-12-10 | 2016-02-12 | ハー・ルンドベック・アクチエゼルスカベット | ニコチン性アセチルコリン受容体の新規な陽性アロステリックモジュレータ |
| JP2016523963A (ja) | 2013-07-08 | 2016-08-12 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | アリールアミドキナーゼ阻害剤 |
| CN105979950A (zh) | 2013-10-11 | 2016-09-28 | 百时美施贵宝公司 | 吡咯并三嗪激酶抑制剂 |
| CN113005089A (zh) * | 2019-12-20 | 2021-06-22 | 泰州医药城国科化物生物医药科技有限公司 | 一种无标记细胞膜受体gpr88的细胞筛选模型及应用 |
| CN111592531B (zh) * | 2020-06-23 | 2023-08-15 | 上海鲲博玖瑞医药科技发展有限公司 | 福瑞塞替的制备方法 |
| GB202209195D0 (en) | 2022-06-22 | 2022-08-10 | Pandeia Therapeutics Ltd | Modulators of g protein-coupled receptor 88 |
| GB202209193D0 (en) | 2022-06-22 | 2022-08-10 | Pandeia Therapeutics Ltd | Modulators of g protein-coupled receptor 88 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0672031B1 (en) | 1992-12-02 | 2003-03-12 | Pfizer Inc. | Catechol diethers as selective pde iv inhibitors |
| US5709861A (en) | 1993-04-22 | 1998-01-20 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
| WO2000021910A2 (en) * | 1998-10-14 | 2000-04-20 | Ortho-Mcneil Pharmaceutical, Inc. | 1,2-disubstituted cyclopropanes |
| JP2005522489A (ja) | 2002-04-05 | 2005-07-28 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | システインプロテアーゼの可逆性インヒビターとして有用なシアナミド |
| WO2003103666A2 (en) | 2002-06-07 | 2003-12-18 | Altana Pharma Ag | Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones |
| EP1565190A4 (en) | 2002-11-22 | 2006-04-26 | Bristol Myers Squibb Co | ARYLCYCLOPROPYLCARBOXYLIC ACID AMIDE AS A KALIUM CHANNEL OPENER |
| WO2004056744A1 (en) | 2002-12-23 | 2004-07-08 | Janssen Pharmaceutica N.V. | Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
| WO2004072018A1 (ja) | 2003-02-12 | 2004-08-26 | Takeda Pharmaceutical Company Limited | アミン誘導体 |
| WO2005000309A2 (en) | 2003-06-27 | 2005-01-06 | Ionix Pharmaceuticals Limited | Chemical compounds |
| WO2005051890A1 (en) | 2003-11-19 | 2005-06-09 | Smithkline Beecham Corporation | Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| CA2570694A1 (en) | 2004-06-24 | 2006-02-02 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| AU2005281783A1 (en) | 2004-09-10 | 2006-03-16 | Ucb Pharma, S.A. | Sigma receptor ligands |
| WO2006097817A1 (en) * | 2005-03-17 | 2006-09-21 | Pfizer Japan Inc. | N- (n-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain |
| CN100494167C (zh) | 2005-08-02 | 2009-06-03 | 天津大学 | 抗乙肝病毒的叔胺氧化物及制备方法和制备药物的应用 |
| JP2007217408A (ja) | 2006-01-19 | 2007-08-30 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| DK2007756T3 (en) | 2006-04-07 | 2015-10-05 | Vertex Pharma | MODULATORS OF ATP BINDING CASSETTE TRANSPORT |
| WO2007129188A1 (en) | 2006-05-10 | 2007-11-15 | Pfizer Japan Inc. | Cyclopropanecarboxamide compound |
| US20080039535A1 (en) | 2006-08-14 | 2008-02-14 | Wyeth | Methods of identifying agents for treating neurological disorders |
| US8426414B2 (en) | 2009-10-09 | 2013-04-23 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
| US8304577B2 (en) | 2009-10-09 | 2012-11-06 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
-
2010
- 2010-10-01 US US12/895,916 patent/US8497271B2/en active Active
- 2010-10-06 IN IN2876DEN2012 patent/IN2012DN02876A/en unknown
- 2010-10-06 WO PCT/US2010/051572 patent/WO2011044195A1/en not_active Ceased
- 2010-10-06 CN CN2010800552740A patent/CN102686575A/zh active Pending
- 2010-10-06 EP EP10765715.7A patent/EP2486030B1/en not_active Not-in-force
- 2010-10-06 ES ES10765715T patent/ES2428492T3/es active Active
- 2010-10-06 JP JP2012533264A patent/JP2013507369A/ja not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014520785A (ja) * | 2011-07-08 | 2014-08-25 | ハー・ルンドベック・アクチエゼルスカベット | ニコチン性アセチルコリン受容体の陽性アロステリックモジュレーター |
Also Published As
| Publication number | Publication date |
|---|---|
| US8497271B2 (en) | 2013-07-30 |
| WO2011044195A1 (en) | 2011-04-14 |
| US20110245264A1 (en) | 2011-10-06 |
| CN102686575A (zh) | 2012-09-19 |
| EP2486030A1 (en) | 2012-08-15 |
| ES2428492T3 (es) | 2013-11-08 |
| IN2012DN02876A (enExample) | 2015-07-24 |
| EP2486030B1 (en) | 2013-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013507369A (ja) | Ｇタンパク質共役受容体８８の調節因子 | |
| CA2691987C (en) | Antibacterial agents | |
| US8426414B2 (en) | Modulators of G protein-coupled receptor 88 | |
| CA2660133C (en) | Thiophenecarboxamide derivatives as ep4 receptor ligands | |
| AU2015237788B2 (en) | ROR-gamma modulators and uses thereof | |
| US8304577B2 (en) | Modulators of G protein-coupled receptor 88 | |
| MX2014012989A (es) | Compuestos novedosos. | |
| JP2005535659A (ja) | 嘔吐、抑鬱、不安および咳の処置のためのニューロキニン−１（ｎｋ−１）アンタゴニストとしての１−アミド−４−フェニル−４−ベンジルオキシメチル−ピペリジン誘導体および関連化合物 | |
| BG107229A (bg) | Циклопентил-заместени глутарамидни производни като инхибитори на неутрална ендопептидаза | |
| CA3095451A1 (en) | Ox2r compounds | |
| JP6754828B2 (ja) | ピリジン及びピリミジン誘導体 | |
| RU2382029C2 (ru) | Новые производные циклогексана | |
| US20100261772A1 (en) | Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators | |
| US7335673B2 (en) | 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage | |
| CN118541348A (zh) | 4-取代-苯基乙酰胺和芳基脲作为孤儿受体gpr88的激动剂 | |
| US8404741B2 (en) | Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase | |
| TWI330181B (en) | Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity | |
| US20240124408A1 (en) | Substituted Cyclohexanecarboxamides, Their Preparation and Their Therapeutic Application | |
| CN102333569A (zh) | 作为GlyT1抑制剂的胺或氨基醇化合物 | |
| HK1234389B (zh) | 作为taar调节剂的6-氨基-5，6，7，8-四氢萘-2-基或3-氨基色满-7-基衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131001 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20131001 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20141030 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20141106 |